scholarly journals OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Retrovirology ◽  
2009 ◽  
Vol 6 (S3) ◽  
Author(s):  
D Salmon-Céron ◽  
C Durier ◽  
C Desaint ◽  
Cuzin ◽  
M Surenaud ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Hiv 1

scholarly journals Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

2014 ◽  
Vol 14 (4) ◽  
pp. 291-300 ◽  
Author(s):  
Richard B Pollard ◽  
Jürgen K Rockstroh ◽  
Giuseppe Pantaleo ◽  
David M Asmuth ◽  
Barry Peters ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Therapeutic Vaccine ◽  
Phase 2 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Hiv 1

scholarly journals Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo controlled trial

Maturitas ◽  
2017 ◽  
Vol 100 ◽  
pp. 142-143
Author(s):  
Julia Prague ◽  
Rachel Roberts ◽  
Alexander Comninos ◽  
Sophie Clarke ◽  
Channa Jayasena ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Hot Flushes ◽  
Phase 2 ◽  
Double Blind ◽  
Receptor Antagonism ◽  
Double Blind Placebo ◽  
Novel Treatment ◽  
Neurokinin 3 Receptor
Sign in / Sign up

Export Citation Format

Share Document